Politics and Society
Truvada pill cuts HIV spread by 86 %, study says
Truvada contains the HIV treatment drugs tenofovir and emtricitabine, which may prevent HIV infections among men who have sex with other men, according to a study done in England
Truvada contains the HIV treatment drugs tenofovir and emtricitabine, which may prevent HIV infections among men who have sex with other men, according to a study done in England
Published
10 years agoon
On Tuesday, the UK Medical Research Council released results of a study showing the Truvada drug cut the spread of HIV, by 86 percent among men who had sex with other men.
The participants took it one day before sex and up to two days after, and a total of 545 men were surveyed. Those who took part were considered to have a high risk of being infected by HIV, because they were having sex about 10 times a month, with eight partners every two months.
The AFP reports that the University of Washington is leading a trial in Kenya and Uganda, to test whether heterosexual partners (one HIV + and the other HIV -), can benefit from the strategy employed in the latest study. (Pre-exposure prophylaxis).
HIV breakthrough: drug trial shows injection twice a year is 100% effective against infection
Breaking Barriers: Repositioning Africa in the global health architecture
Zimbabwe approves long-acting drug to advance HIV prevention
New research: Cancer drug with potential to be used against malaria
Vaccines could be a game-changer in the fight against malaria in Africa
Flesh tones in prosthetics